CD4-mediated signals induce T cell dysfunction in vivo

Narendra Chirmule, Andris Avots, S. M. LakshmiTamma, Savita G Pahwa, Edgar Serfling

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Triggering of CD4 coreceptors on both human and murine T cells can suppress TCR/CD3-induced secretion of IL-2. We show here that pretreatment of murine CD4+ T cells with the CD4-specific mAb YTS177 inhibits the CD3- mediated activation of the IL-2 promoter factors NF-AT and AP-1. Ligation of CD4 molecules on T cells leads to a transient stimulation of extracellullar signal regulated kinase (Erk) 2, but not c-Jun N-terminal kinase (JNK) activity. Pretreatment with anti-CD4 mAb impaired anti-CD3 induced Erk2 activation. Costimulation with anti-CD28 overcame the inhibitory effect of anti-CD4 Abs, by induction of JNK activation. The in vivo relevance of these studies was demonstrated by the observation that CD4+ T cells from BALB/c mice injected with nondepleting anti-CD4 mAb were inhibited in their ability to respond to OVA Ag-induced proliferation and IL-2 secretion. Interestingly, in vivo stimulation with ant-CD28 mAb restored IL-2 secretion. Furthermore, animals pretreated with anti-CD4 elicited enhanced IL-4 secretion induced by OVA and CD28. These observations suggest that CD4-specific Abs can inhibit T cell activation by interfering with signal 1 transduced through the TCR, but potentiate those delivered through the costimulatory molecule CD28. These studies have relevance to understanding the mechanism of tolerance induced by nondepleting anti-CD4 mAb used in animal models for allograft studies, autoimmune pathologies, and for immunosuppressive therapies in humans.

Original languageEnglish
Pages (from-to)644-649
Number of pages6
JournalJournal of Immunology
Volume163
Issue number2
StatePublished - Jul 15 1999
Externally publishedYes

Fingerprint

Interleukin-2
T-Lymphocytes
Mitogen-Activated Protein Kinase 9
CD4 Antigens
Ants
JNK Mitogen-Activated Protein Kinases
Transcription Factor AP-1
Immunosuppressive Agents
Interleukin-4
Allografts
Ligation
Phosphotransferases
Animal Models
Pathology
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Chirmule, N., Avots, A., LakshmiTamma, S. M., Pahwa, S. G., & Serfling, E. (1999). CD4-mediated signals induce T cell dysfunction in vivo. Journal of Immunology, 163(2), 644-649.

CD4-mediated signals induce T cell dysfunction in vivo. / Chirmule, Narendra; Avots, Andris; LakshmiTamma, S. M.; Pahwa, Savita G; Serfling, Edgar.

In: Journal of Immunology, Vol. 163, No. 2, 15.07.1999, p. 644-649.

Research output: Contribution to journalArticle

Chirmule, N, Avots, A, LakshmiTamma, SM, Pahwa, SG & Serfling, E 1999, 'CD4-mediated signals induce T cell dysfunction in vivo', Journal of Immunology, vol. 163, no. 2, pp. 644-649.
Chirmule N, Avots A, LakshmiTamma SM, Pahwa SG, Serfling E. CD4-mediated signals induce T cell dysfunction in vivo. Journal of Immunology. 1999 Jul 15;163(2):644-649.
Chirmule, Narendra ; Avots, Andris ; LakshmiTamma, S. M. ; Pahwa, Savita G ; Serfling, Edgar. / CD4-mediated signals induce T cell dysfunction in vivo. In: Journal of Immunology. 1999 ; Vol. 163, No. 2. pp. 644-649.
@article{e0edc967c23a4261968c4cd1eb2fd653,
title = "CD4-mediated signals induce T cell dysfunction in vivo",
abstract = "Triggering of CD4 coreceptors on both human and murine T cells can suppress TCR/CD3-induced secretion of IL-2. We show here that pretreatment of murine CD4+ T cells with the CD4-specific mAb YTS177 inhibits the CD3- mediated activation of the IL-2 promoter factors NF-AT and AP-1. Ligation of CD4 molecules on T cells leads to a transient stimulation of extracellullar signal regulated kinase (Erk) 2, but not c-Jun N-terminal kinase (JNK) activity. Pretreatment with anti-CD4 mAb impaired anti-CD3 induced Erk2 activation. Costimulation with anti-CD28 overcame the inhibitory effect of anti-CD4 Abs, by induction of JNK activation. The in vivo relevance of these studies was demonstrated by the observation that CD4+ T cells from BALB/c mice injected with nondepleting anti-CD4 mAb were inhibited in their ability to respond to OVA Ag-induced proliferation and IL-2 secretion. Interestingly, in vivo stimulation with ant-CD28 mAb restored IL-2 secretion. Furthermore, animals pretreated with anti-CD4 elicited enhanced IL-4 secretion induced by OVA and CD28. These observations suggest that CD4-specific Abs can inhibit T cell activation by interfering with signal 1 transduced through the TCR, but potentiate those delivered through the costimulatory molecule CD28. These studies have relevance to understanding the mechanism of tolerance induced by nondepleting anti-CD4 mAb used in animal models for allograft studies, autoimmune pathologies, and for immunosuppressive therapies in humans.",
author = "Narendra Chirmule and Andris Avots and LakshmiTamma, {S. M.} and Pahwa, {Savita G} and Edgar Serfling",
year = "1999",
month = "7",
day = "15",
language = "English",
volume = "163",
pages = "644--649",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - CD4-mediated signals induce T cell dysfunction in vivo

AU - Chirmule, Narendra

AU - Avots, Andris

AU - LakshmiTamma, S. M.

AU - Pahwa, Savita G

AU - Serfling, Edgar

PY - 1999/7/15

Y1 - 1999/7/15

N2 - Triggering of CD4 coreceptors on both human and murine T cells can suppress TCR/CD3-induced secretion of IL-2. We show here that pretreatment of murine CD4+ T cells with the CD4-specific mAb YTS177 inhibits the CD3- mediated activation of the IL-2 promoter factors NF-AT and AP-1. Ligation of CD4 molecules on T cells leads to a transient stimulation of extracellullar signal regulated kinase (Erk) 2, but not c-Jun N-terminal kinase (JNK) activity. Pretreatment with anti-CD4 mAb impaired anti-CD3 induced Erk2 activation. Costimulation with anti-CD28 overcame the inhibitory effect of anti-CD4 Abs, by induction of JNK activation. The in vivo relevance of these studies was demonstrated by the observation that CD4+ T cells from BALB/c mice injected with nondepleting anti-CD4 mAb were inhibited in their ability to respond to OVA Ag-induced proliferation and IL-2 secretion. Interestingly, in vivo stimulation with ant-CD28 mAb restored IL-2 secretion. Furthermore, animals pretreated with anti-CD4 elicited enhanced IL-4 secretion induced by OVA and CD28. These observations suggest that CD4-specific Abs can inhibit T cell activation by interfering with signal 1 transduced through the TCR, but potentiate those delivered through the costimulatory molecule CD28. These studies have relevance to understanding the mechanism of tolerance induced by nondepleting anti-CD4 mAb used in animal models for allograft studies, autoimmune pathologies, and for immunosuppressive therapies in humans.

AB - Triggering of CD4 coreceptors on both human and murine T cells can suppress TCR/CD3-induced secretion of IL-2. We show here that pretreatment of murine CD4+ T cells with the CD4-specific mAb YTS177 inhibits the CD3- mediated activation of the IL-2 promoter factors NF-AT and AP-1. Ligation of CD4 molecules on T cells leads to a transient stimulation of extracellullar signal regulated kinase (Erk) 2, but not c-Jun N-terminal kinase (JNK) activity. Pretreatment with anti-CD4 mAb impaired anti-CD3 induced Erk2 activation. Costimulation with anti-CD28 overcame the inhibitory effect of anti-CD4 Abs, by induction of JNK activation. The in vivo relevance of these studies was demonstrated by the observation that CD4+ T cells from BALB/c mice injected with nondepleting anti-CD4 mAb were inhibited in their ability to respond to OVA Ag-induced proliferation and IL-2 secretion. Interestingly, in vivo stimulation with ant-CD28 mAb restored IL-2 secretion. Furthermore, animals pretreated with anti-CD4 elicited enhanced IL-4 secretion induced by OVA and CD28. These observations suggest that CD4-specific Abs can inhibit T cell activation by interfering with signal 1 transduced through the TCR, but potentiate those delivered through the costimulatory molecule CD28. These studies have relevance to understanding the mechanism of tolerance induced by nondepleting anti-CD4 mAb used in animal models for allograft studies, autoimmune pathologies, and for immunosuppressive therapies in humans.

UR - http://www.scopus.com/inward/record.url?scp=0033565271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033565271&partnerID=8YFLogxK

M3 - Article

C2 - 10395653

AN - SCOPUS:0033565271

VL - 163

SP - 644

EP - 649

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -